Insufficient scRNA-seq data for expression of TRIM35 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM35 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1370.76 | 1445 / 1445 | 100% | 21.50 | 183 / 183 |
breast | 100% | 1679.51 | 459 / 459 | 100% | 15.55 | 1116 / 1118 |
intestine | 100% | 1079.13 | 966 / 966 | 100% | 15.31 | 526 / 527 |
prostate | 100% | 1366.94 | 245 / 245 | 100% | 12.79 | 501 / 502 |
skin | 100% | 5111.03 | 1809 / 1809 | 100% | 24.82 | 471 / 472 |
kidney | 100% | 1117.99 | 89 / 89 | 100% | 20.21 | 899 / 901 |
thymus | 100% | 976.42 | 652 / 653 | 100% | 18.77 | 603 / 605 |
bladder | 100% | 1143.19 | 21 / 21 | 99% | 14.14 | 501 / 504 |
uterus | 100% | 1434.99 | 170 / 170 | 99% | 17.29 | 456 / 459 |
lung | 99% | 1214.25 | 572 / 578 | 100% | 15.62 | 1153 / 1155 |
brain | 99% | 950.62 | 2609 / 2642 | 100% | 21.38 | 705 / 705 |
ovary | 99% | 977.73 | 179 / 180 | 99% | 10.95 | 426 / 430 |
adrenal gland | 100% | 1181.66 | 258 / 258 | 98% | 18.21 | 225 / 230 |
stomach | 98% | 816.99 | 351 / 359 | 100% | 16.44 | 286 / 286 |
pancreas | 97% | 663.63 | 319 / 328 | 99% | 13.65 | 177 / 178 |
liver | 100% | 1249.11 | 226 / 226 | 94% | 13.01 | 382 / 406 |
adipose | 100% | 1700.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 16.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.39 | 29 / 29 |
spleen | 100% | 1228.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.66 | 1 / 1 |
blood vessel | 100% | 1239.58 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 93% | 560.85 | 749 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 585.86 | 799 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 683.96 | 751 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045087 | Biological process | innate immune response |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | TRIM35 |
Protein name | Tripartite motif containing 35 E3 ubiquitin-protein ligase TRIM35 (EC 2.3.2.27) (Hemopoietic lineage switch protein 5) |
Synonyms | HLS5 KIAA1098 |
Description | FUNCTION: E3 ubiquitin-protein ligase that participates in multiple biological processes including cell death, glucose metabolism, and in particular, the innate immune response. Mediates 'Lys-63'-linked polyubiquitination of TRAF3 thereby promoting type I interferon production via RIG-I signaling pathway . Can also catalyze 'Lys-48'-linked polyubiquitination and proteasomal degradation of viral proteins such as influenza virus PB2 . Acts as a negative feedback regulator of TLR7- and TLR9-triggered signaling. Mechanistically, promotes the 'Lys-48'-linked ubiquitination of IRF7 and induces its degradation via a proteasome-dependent pathway . Reduces FGFR1-dependent tyrosine phosphorylation of PKM, inhibiting PKM-dependent lactate production, glucose metabolism, and cell growth . . |
Accessions | Q9UPQ4 H0YBF3 ENST00000305364.9 [Q9UPQ4-1] E5RGB3 ENST00000521253.1 ENST00000521283.1 |